1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REPLIGEN CORP.
124.49 -3.40 (-2.66%)
152.3K
XNAS Volume

XNAS 10 Mar, 2026 10:20 AM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for Repligen Corp is on 18 Mar 2026 for the purpose of KBCM Virtual Healthcare Forum See details

US Politician trade disclosures for Repligen Corp from May 8, 2025 to March 10, 2026

Representative Lisa McClain discloses a trade of $1K-15K in Repligen Corp, made on November 24, 2025.

Members of Congress or their families often buy or sell securities and have access to non-public information through their roles. The STOCK Act requires them to report these trades within 45 days to ensure transparency and reduce conflicts of interest.